Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies.
Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies. Implement Sci Commun. 2024 Apr 09; 5(1):37.
PMID: 38594740
Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer.
Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer. Ann Fam Med. 2024 Jan-Feb; 22(1):5-11.
PMID: 38253492
Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study.
Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study. Cancer Med. 2023 Dec 27.
PMID: 38151901
Industry Payments for Vibegron and Prescribing Patterns Among Urologic Clinicians.
Industry Payments for Vibegron and Prescribing Patterns Among Urologic Clinicians. JAMA Health Forum. 2023 Dec 01; 4(12):e234020.
PMID: 38127590
National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer.
National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer. Urology. 2024 Feb; 184:135-141.
PMID: 37951360
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System.
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System. JCO Oncol Pract. 2024 Jan; 20(1):59-68.
PMID: 38085028
Using Implementation Science to Improve Patient Care.
Using Implementation Science to Improve Patient Care. J Urol. 2023 10; 210(4):577-579.
PMID: 37578467
Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.
Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice. J Urol. 2023 Nov; 210(5):771-777.
PMID: 37566643
Industry Payments to Urologists and Urologic Advanced Practice Providers in 2021.
Industry Payments to Urologists and Urologic Advanced Practice Providers in 2021. Urology. 2023 Oct; 180:121-129.
PMID: 37517679
Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system.
Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system. Cancer. 2023 10 15; 129(20):3326-3333.
PMID: 37389814